Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00LOL
|
|||
| Former ID |
DIB019431
|
|||
| Drug Name |
PMID23849879C3
|
|||
| Synonyms |
SMR000144080; MLS000537840; AC1LJ8QE; GTPL8488; cid_970375; BDBM32709; MolPort-002-093-912; HMS2464J20; HMS1593B09; ZINC609776; STK138150; AKOS001696771; MCULE-4952162555; SR-01000666149; SR-01000666149-2
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C15H13N5O
|
|||
| Canonical SMILES |
CC1=CC=C(C=C1)C(=O)N2C(=NC(=N2)C3=CN=CC=C3)N
|
|||
| InChI |
1S/C15H13N5O/c1-10-4-6-11(7-5-10)14(21)20-15(16)18-13(19-20)12-3-2-8-17-9-12/h2-9H,1H3,(H2,16,18,19)
|
|||
| InChIKey |
BIEYFOHSWAIQDF-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Kallikrein-14 (KLK14) | Target Info | Inhibitor | [1] |
| Kallikrein-5 (KLK5) | Target Info | Inhibitor | [1] | |
| Kallikrein-7 (KLK7) | Target Info | Inhibitor | [1] | |
| Suppressor of tumorigenicity 14 protein (ST14) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | MicroRNAs in cancer | |||
| NetPath Pathway | TCR Signaling Pathway | |||
| Reactome | Degradation of the extracellular matrix | |||
| WikiPathways | Hair Follicle Development: Cytodifferentiation (Part 3 of 3) | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett. 2013 Aug 15;23(16):4547-51. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.